Revolution Medicines trust plans 73K share sale

Revolution Medicines, Inc. (RVMD) is the issuer of common stock that an affiliate, the Kim Revocable Trust (with Lorence H. Kim as trustee), has filed to sell under Rule 144.

Rhea-AI Filing Summary

Revolution Medicines, Inc. (RVMD) is the issuer of common stock that an affiliate, the Kim Revocable Trust (with Lorence H. Kim as trustee), has filed to sell under Rule 144. The planned sale covers 73,090 shares of common stock through J.P. Morgan Securities LLC, listed on Nasdaq. These shares were acquired by a 50,000-share open‑market purchase on July 20, 2022 and by restricted stock unit (RSU) vesting in several tranches totaling 23,090 shares between December 15, 2022 and June 26, 2026. The notice states that RVMD had 214,336,418 shares outstanding as of August 31, 2026, providing context for the size of the planned sale relative to total shares.

Key Figures

Shares to be sold: 73,090 shares of common stock Aggregate market value: 15,193,949.2 Shares outstanding: 214,336,418 shares +5 more

8 metrics

Shares to be sold 73,090 shares of common stock Number of RVMD shares covered by the Rule 144 notice

Aggregate market value 15,193,949.2 Aggregate market value of the 73,090 RVMD shares to be sold

Shares outstanding 214,336,418 shares RVMD common shares outstanding as of August 31, 2026

Open market purchase 50,000 shares Shares acquired by purchase on July 20, 2022

RSU vesting tranche 10,500 shares RSU vesting on December 15, 2022

RSU vesting tranche 5,200 shares RSU vesting on June 15, 2024

RSU vesting tranche 4,248 shares RSU vesting on June 20, 2025

RSU vesting tranche 3,142 shares RSU vesting on June 26, 2026

Key Terms

Rule 144, affiliate, RSU Vesting, aggregate market value, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

affiliate regulatory

"In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice. Affiliate"

RSU Vesting financial

"Common | 12/15/2022 | RSU Vesting | Issuer"

RSU vesting is the process by which restricted stock units — a promise by a company to give shares to an employee — become actual, owned shares over time or when certain goals are met. Investors care because vested shares can dilute existing ownership when issued, and the timing of vesting affects when employees can sell shares, which can influence share supply, insider selling patterns, and company incentives.

aggregate market value financial

"Common | J.P. Morgan Securities LLC ... | 73090 | 15193949.2 | 214336418 | 08/31/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact regulatory

"J.P. Morgan Securities LLC as agent and attorney-in-fact for Lorence H Kim"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing disclose for RVMD?

It discloses that an affiliate of Revolution Medicines, Inc. (RVMD), the Kim Revocable Trust with Lorence H. Kim as trustee, has filed a notice of intent under Rule 144 to sell 73,090 shares of RVMD common stock through J.P. Morgan Securities LLC on Nasdaq.

How many RVMD shares are planned to be sold under this Form 144?

The filing states that 73,090 shares of RVMD common stock are planned to be sold. The aggregate market value associated with this amount is listed as 15,193,949.2, with the sale to be executed through J.P. Morgan Securities LLC on Nasdaq.

Who is selling the RVMD shares in this Form 144 notice?

The shares are being sold for the account of Lorence H. Kim via the Kim Revocable Trust, with J.P. Morgan Securities LLC acting as agent and attorney‑in‑fact. The seller is identified as an affiliate of Revolution Medicines, Inc.

How were the 73,090 RVMD shares being sold acquired?

The filing states the shares were acquired via a 50,000‑share open‑market purchase on July 20, 2022 and through RSU vesting in four tranches of 10,500, 5,200, 4,248, and 3,142 shares vesting between December 15, 2022 and June 26, 2026.

What is the aggregate market value of the RVMD shares in this Form 144?

The Form 144 lists an aggregate market value of 15,193,949.2 for the 73,090 shares of RVMD common stock covered by the planned Rule 144 sale through J.P. Morgan Securities LLC.

How many RVMD shares were outstanding when this Form 144 was filed?

The notice states that 214,336,418 shares of Revolution Medicines, Inc. common stock were outstanding as of August 31, 2026, providing a reference point for the relative size of the 73,090‑share planned sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 05:11 PM Accepted by SEC EDGAR 08/31/2026 - 05:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001643746
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 Saginaw Drive Redwood City CALIFORNIA 94063
Phone	650-481-6801
Name of Person for Whose Account the Securities are To Be Sold	Lorence H Kim
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue - 10th Floor New York NY 10017	73090	15193949.2	214336418	08/31/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/20/2022	Purchase	Open Market			50000	07/20/2022	N/A
Common	12/15/2022	RSU Vesting	Issuer			10500	12/15/2022	N/A
Common	06/15/2024	RSU Vesting	Issuer			5200	06/15/2024	N/A
Common	06/20/2025	RSU Vesting	Issuer			4248	06/20/2025	N/A
Common	06/26/2026	RSU Vesting	Issuer			3142	06/26/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares represented on this filing were received as purchase and via RSU vesting during acquired between 07/20/22 and 06/26/2026. The shares are being sold by the Kim Revocable Trust, Lorence H Kim, as Trustee.
Date of Notice	08/31/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Lorence H Kim
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)